ArborGen Holdings (ARB) H1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2025 earnings summary
13 Jun, 2025Executive summary
Revenue for 1H25 declined 3% to $12.8m after a record 78% increase in 1H24, but remains well above 1H23 levels.
Net loss after tax was $(2.1)m, compared to $(0.1)m in 1H24, reflecting softer market conditions and higher costs.
Strategic progress included streamlining US operations, expanding nursery capacity in Brazil, and launching a share buyback.
Majority of 1H25 revenue was from Brazil, with US sales recognized mainly in the second half of the year.
Financial highlights
Sales revenue: $12.8m (down 3% vs 1H24; up from $7.4m in 1H23).
Gross profit: $3.1m (down from $4.8m in 1H24).
Adjusted US GAAP EBITDA: $(2.7)m, excluding $2m in one-off items.
Net debt increased to $19.9m from $16.7m in 1H24, mainly due to working capital timing and capex.
Cash at period end: $4.3m.
Outlook and guidance
FY25 Adjusted US GAAP EBITDA expected between $8.5m and $10m, down from $12.8m in FY24.
Softer sales volumes anticipated due to ongoing market headwinds in the US South, partially offset by expected growth in Brazil in 2H25.
Long-term demand trends in both the US and Brazil remain positive, with recovery in US saw timber demand projected to start mid-2025.
Latest events from ArborGen Holdings
- Revenue declined but growth, advanced genetics, and carbon market expansion remain priorities.ARB
AGM 20253 Feb 2026 - Record revenue, share buyback, and Brazil-led growth amid market and weather challenges.ARB
AGM 202423 Jan 2026 - Record revenue and improved margins driven by Brazil; FY26 EBITDA growth of at least 25% expected.ARB
H1 202625 Nov 2025 - $21.8m impairment and weak sales led to a sharp net loss and equity drop.ARB
H2 202521 Jun 2025 - Record revenue and EBITDA driven by Brazil growth and US resilience, with strong FY25 outlook.ARB
H2 202413 Jun 2025